[Skip to Navigation]
Sign In
Comment & Response
August 6, 2020

Assessing Expression of PD-L1 in Tumor-Associated Macrophages—Reply

Author Affiliations
  • 1Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick
  • 2Department of Radiation Oncology, New York Proton Center, New York, New York
JAMA Oncol. 2020;6(10):1634-1635. doi:10.1001/jamaoncol.2020.2722

In Reply We would like to thank Zhang et al for their interest in our recent phase 1 nonrandomized controlled trial of chemoradiotherapy with concurrent pembrolizumab for the treatment of locally advanced non–small cell lung cancer (NSCLC)1 and are appreciative of their thoughtful inquiries regarding this work. We would like to address their points in order, as follows.

Add or change institution